TP B1: Applied longitudinal transcriptomics of autoreactive B cells in pemphigus patients
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are two potentially life-threatening autoimmune blistering skin diseases, that are characterized by pathologic anti-desmoglein autoantibodies and autoreactive B cells that produce them.Longitudinal analyses of the transcriptomes of these autoreactive B cells before and after therapy by RNA-sequencing should allow insights into molecular pathways of the disease and the current treatments.Therefore Pathways associated with induction of remission may be exploited for testing of new, more targeted treatment strategies.
- Projects
- Projects
- Associated projects
- MD projects
- Associated MD projects
- Concluded projects
- Concluded TP
- TP1 - Modulation of isotypes
- TP2 - Targeted fusion proteins
- TP3 - Selective FcRn inhibition
- TP4 - IL-35, Treg and EAE
- TP5 - Apoptotic cells
- TP6 - Mast cell / T cell interactions
- TP7 - Fc gamma receptors
- TP8 - IgG- and C-receptors
- TP9 - IVIG
- TP10 - HMGB1 Protein
- TP11 - IL15 / IL15Rα
- TP12 - S100 proteins
- TP13 - Treatment-refractory B cells
- TP A1 - Treatment strategies
- TP A2 - B cell inhibition
- TP A3 - IL-17 in EBA
- TP A4 - The pathophysiological role of Th17cells in Bullous pemphigoid
- TP A5 - C5a/C5aR
- TP A6 - Signals leading to glycosylated antibodies
- TP A7 - IL-16 & MIF in autoimmunity
- TP B1 - B cell transcriptome
- TP B2 - Antigen-specific T cells
- TP B3 - Metabolomics
- TP B4 - Resident plasma cells
- TP B5 - Anti-CD37 antibodies
- TP B6 - Systemic Sclerosis
- Concluded Ass.TP
- Concluded MD TP
- Concluded Ass. MD TP
- Concluded TP
Principal investigator(s)
Mentors
PhD student
Christoph Hammers, MD